Search
for
Sort by
Research 391–420 of 1000+
- Post-finasteride syndrome: pharmacists must lead the conversation on patient safety
- Oxidative Stress and Hormone-regulated Dermal Papilla Cell-targeted Nanomodulators: Reverse Cellular Senescence for Androgenetic Alopecia Therapy
- Androgenetic alopecia: combing the hair follicle signaling pathways for new therapeutic targets and more effective treatment options
- Ethosomes: An Exciting and Promising Alcoholic Carrier System for Treating Androgenic Alopecia
- An Androgenetic Alopecia Remedy Based on Marine Collagen Peptide-Incorporated Dissolving Microneedles
- Faculty Opinions recommendation of Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis.
- Antiandrogens and Androgen Inhibitors
- Multifunctional hydrogel based on oxidized sodium alginate and carboxymethyl chitosan delivers minoxidil loaded liposomes for the treatment of androgenetic alopecia
- Current management of androgenetic alopecia in men.
- 479 Transcriptomics identifies potential novel therapeutic targets in androgenetic alopecia
- Optimal use of topical minoxidil in management of female pattern hair loss in India: an expert opinion
- Androgen receptor signaling as a new target for intervention in acute myeloid leukemia
- Microneedles self-implanting Astragalus polysaccharides-hybridized composite hydrogel combined with minoxidil to enhance in situ anti-androgenetic alopecia.
- Fractional non-ablative laser-assisted drug delivery leads to improvement in male and female pattern hair loss
- The Mechanisms of Anabolic Steroids, Selective Androgen Receptor Modulators and Myostatin Inhibitors
- Dutasteride-loaded nanostructured lipid carrier for androgenic alopecia treatment - An <i>in vivo</i> study.
- Emerging pharmacotherapies and regenerative solutions for promoting hair growth for androgenetic alopecia
- Natural Sweetener Stevioside‐Based Dissolving Microneedles Solubilize Minoxidil for the Treatment of Androgenic Alopecia (Adv. Healthcare Mater. 2/2026)
- Reversible Myopathy and Ophthalmoparesis After Low-Dose Finasteride Administration for Androgenic Alopecia
- Androgenetic alopecia and current methods of treatment.
- Androgenetic alopecia in men: the scale of the problem and prospects for treatment.
- Cationic nanoemulsions enable follicle-associated delivery with reduced systemic exposure for combined minoxidil/finasteride therapy against androgenetic alopecia
- What are the causes and management of androgenetic alopecia in women?
- What are the causes and management of androgenetic alopecia in women?
- Synthesis of novel andostane-N-cyclohexyl-17-carboxamides, and their effect on the 5α-reductase isoform 2, the androgen receptor, and androgen-dependent glands
- Non-Steroidal Modulation of the 5-Alpha Reductase Axis: A Dual Therapeutic Strategy for Prostatic Chemoprevention and Androgenetic Alopecia
- Steroid 5α-reductases and 3α-hydroxysteroid dehydrogenases: key enzymes in androgen metabolism
- Enhanced hair follicle accumulation and androgenetic alopecia treatment of finasteride by topical nanoparticles hydrogel system
- The Pathogenesis and Treatment Progress of Androgenic Alopecia
- Potential targets in the discovery of new hair growth promoters for androgenic alopecia